A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)

Running, not enrolling · Phase 2 · Has a placebo group

Conditions studied: Rheumatoid Arthritis

In brief

RENOIR Study: This study will evaluate the safety, tolerability, and efficacy of Rosnilimab in subjects with moderate to severe Rheumatoid Arthritis (RA)

Key facts

Study ID

NCT06041269

Run by

AnaptysBio, Inc.

People needed

420

Starts

2023-08-31

Expected to finish

2025-05-30

Last updated by the study team

2024-11-25

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• AnaptysBio Investigative Site 10-130 — Glendale, Arizona, United States
• AnaptysBio Investigative Site 10-129 — Phoenix, Arizona, United States
• AnaptysBio Investigative Site 10-131 — Tucson, Arizona, United States
• AnaptysBio Investigative Site 10-105 — Covina, California, United States
• Anaptys Bio Investigative Site 10-119 — Rancho Mirage, California, United States
• AnaptysBio Investigative Site 10-113 — San Diego, California, United States
• AnaptysBio Investigative Site 10-127 — San Francisco, California, United States
• AnaptysBio Investigative Site 10-136 — Temecula, California, United States
• AnaptysBio Investigative Site 10-133 — Upland, California, United States
• AnaptysBio Investigative Site 10-112 — Whitter, California, United States
• AnaptysBio Investigative Site 10-103 — Aventura, Florida, United States
• AnaptysBio Investigative Site 10-141 — Avon Park, Florida, United States
• AnaptysBio Investigative Site 10-118 — Boynton Beach, Florida, United States
• AnaptysBio Investigative Site 10-125 — Daytona Beach, Florida, United States
• AnaptysBio Investigative Site 10-122 — Homestead, Florida, United States
• Anaptys Bio Investigative Site 10-142 — Miami, Florida, United States
• AnaptysBio Investigative Site 10-140 — Miami, Florida, United States
• AnaptysBio Investigative Site 10-102 — Miami, Florida, United States
• AnaptysBio Investigative Site 10-124 — Plantation, Florida, United States
• AnaptysBio Investigative Site 10-139 — West Palm Beach, Florida, United States
• AnaptysBio Investigative Site 10-114 — Chicago, Illinois, United States
• AnaptysBio Investigative Site 10-145 — Monroe, Louisiana, United States
• AnaptysBio Investigative Site 10-143 — Brookline, Massachusetts, United States
• AnaptysBio Investigative Site 10-116 — Albuquerque, New Mexico, United States
• AnaptysBio Investigative Site 10-132 — Flagstaff, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.